Atypical myopathy (AM) is a severe
rhabdomyolysis syndrome that
occurs in grazing horses. Despite the presence of toxins in their
blood, all horses from the same pasture are not prone to display clinical
signs of AM. The objective of this study was to compare the blood
metabolomic profiles of horses with AM clinical signs with those of
healthy co-grazing (Co-G) horses. To do so, plasma samples from 5
AM horses and 11 Co-G horses were investigated using untargeted metabolomics.
Metabolomic data were evaluated using unsupervised, supervised, and
pathway analyses. Unsupervised principal component analysis performed
with all detected features separated AM and healthy Co-G horses. Supervised
analyses had identified 1276 features showing differential expression
between both groups. Among them, 46 metabolites, belonging predominantly
to the fatty acid, fatty ester, and amino acid chemical classes, were
identified by standard comparison. Fatty acids, unsaturated fatty
acids, organic dicarboxylic acids, and fatty esters were detected
with higher intensities in AM horses in link with the toxins’
pathological mechanism. The main relevant pathways were lipid metabolism;
valine, leucine, and isoleucine metabolism; and glycine metabolism.
This study revealed characteristic metabolite changes in the plasma
of clinically affected horses, which might ultimately help scientists
and field veterinarians to detect and manage AM. The raw data of metabolomics
are available in the MetaboLights database with the access number
MTBLS2579.